| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 May 2024 | 6 May 2024 |
| Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 inter alia to consider and approve This is to inform you that as required under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the meeting of Board of Directors of the Company is scheduled to be held on Monday 13th May2024 inter-alia to consider and approve the following: 1. The Audited Financial Results of the Company for the quarter and financial year ending on 31st March2024 in accordance with Regulation 33 of the SEBI Listing Regulation. 2. Any other matter with the permission of the chair Appointment of Internal Auditor Appointment of Secretarial Auditor Please refer to attached PDF (As Per BSE Announcement Dated on 13/05/2024) | ||
| Board Meeting | 8 Feb 2024 | 1 Feb 2024 |
| Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve This is to inform you that as required under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the meeting of Board of Directors of the Company is scheduled to be held on Thursday 08th February 2024 inter-alia to consider and approve the following: 1. The Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2023 2. Any other matter with the permission of the chair. Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Thursday, 08th February, 2024, Board, inter-alia, considered and approved the Unaudited Financial Results for the Quarter and nine months ended 31st December,2023. The Statutory Auditors have carried out a Limited Review of the Unaudited Financial Results for the Quarter and nine months ended 31st December 2023. Further, Pursuant to the Regulation 33 of the Listing Regulations, we are enclosing herewith a copy of the Unaudited Financial Results and Limited Review Report of the Statutory Auditors of the Company Financial Results for quarter and nine months ended 31st December,2023 (As Per BSE Announcement dated on 08.02.2024) | ||
| Board Meeting | 25 Jan 2024 | 25 Jan 2024 |
| Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we would like to inform you that the Board of Directors in their meeting held today has considered and approved the below transaction: Company (ELL) to enter into definitive business agreement with Vivacious Pharmatex Private Limited (VPPL) for Companys Growth and strategic positioning. | ||
| Board Meeting | 14 Dec 2023 | 11 Dec 2023 |
| Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/12/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we hereby inform you that a meeting of Rights Issue Committee of Board of Directors the Company is scheduled to be held on Thursday 14th December 2023 to consider inter-alia and to approve the following matters; 1) Matter relating to payment of First and final call money on 5544178 partly paid-up equity shares of face value of Re. 10/- each which were issued and allotted on August 02 2023 on right basis pursuant to the Letter of Offer dated July 07 2023. 2) Any other matter with the permission of the Chair. Thanking You EIKO LIFESCIENCES LIMITED has informed BSE about Board Meeting to be held on 14 Dec 2023 to consider Fund raising. | ||
| Board Meeting | 8 Nov 2023 | 30 Oct 2023 |
| Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve 1. The unaudited financial results of the Company for the quarter and half year ended 30th September 2023. 2. Any other matter with the permission of the chair. Pursuant to Regulation 30 and 33 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we would like to inform you that the Board of Directors in their meeting held today i.e., 08th November,2023 inter-alia, approved the following matters: 1. Considered and approved the Un-audited Financial Results of the Company for the quarter and half year ended on 30th September, 2023 along with the Limited review Report given by Statutory Auditor of the Company (Annexure - A). 2. Appointment of Mr. Chintan B. Doshi (ICSI Membership No. ACS 36190) as a Company Secretary and Compliance Officer pursuant to section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 with immediate effect. (As per BSE Announcement Dated on 08/11/2023) | ||
| Board Meeting | 30 Aug 2023 | 30 Aug 2023 |
| The Board has considered and Approved the following- 1. The Boards Report, Corporate Governance Report, Management Discussion and Analysis Report. 2. Draft notice convening 46th Annual General Meeting of the Members of the Company to be held on Saturday, 23rd September 2023 at 12.30 p.m. (IST) at the registered office of the Company through Video - Conferencing (VC) / Other Audio-Visual Means (OAVM). 3. Friday, September 15, 2023, as the cut-off date to determine the entitlement of voting rights of members for E-voting. 4. Annual Report of the Company for the period ended on 31st March 2023. 5. The remote e-voting period for 46th AGM begins on Wednesday, 20th September 2023 at 9.00 a.m. (IST) and ends on Friday 22nd September 2023 at 5.00 p.m. (IST) | ||
| Board Meeting | 12 Aug 2023 | 12 Aug 2023 |
| Pursuant to provision of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations), the board of Directors, at its meeting held today i.e. on 12th August, 2023 inter alia considered and approved the following: Appointment of Ms. Nilima A. Burghate (ICSI Membership No. ACS 66117) as a new Company Secretary and Compliance Officer pursuant to section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 with immediate effect. The requisite disclosure under regulation 30 of SEBI (LODR), Regulation 2015 read with Circular No. CIR/ CIR/CFD/CMD/4/2015 dated September 9, 2015, and SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-1. The Board Meeting was started at 04.45 p.m. and concluded at 05:30 p.m. Kindly take the same on your records. | ||
| Board Meeting | 2 Aug 2023 | 2 Aug 2023 |
| We hereby inform that, in accordance with (i) the Letter of Offer dated July 07, 2023, and (ii) the Basis of Allotment finalised in consultation with the Registrar to the Issue and BSE Limited, (the Designated Stock Exchange for the Rights issue), the Rights Issue Committee of the Board of Directors of the Company has, at in its meeting held today, i.e., August 02, 2023, approved the allotment of 55,44,156 partly paid-up Equity Shares of face value of Rs. 10/- each on a rights basis, at an issue price of Rs.45 per Equity Share (including premium of Rs.35 per Equity Share) to the eligible applicants. The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs.10.50) paid on Application. Balance to be paid in not more than two calls as determined by our Board at its sole discretion from time to time. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
